Parker Institute for Cancer Immunotherapy
San Francisco, Californiaparkerici.org
Overview
Parker Institute for Cancer Immunotherapy is a non-profit research organization and investor that funds and supports cancer immunotherapy research and invests in biotech startup companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Dispatch Biotherapeutics | Jul 2025 | Series A | Lead |
| ArsenalBio | Sep 2024 | Series C | Co-investor |
| Xaira Therapeutics | Apr 2024 | VC Round | Co-investor |
| Xaira Therapeutics | Apr 2024 | Series A | Co-investor |
| Georgiamune | Aug 2023 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
